Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.
Read the spring 2022 edition of DiversiTEA Corner, the newsletter about inclusion, diversity, equity and accessibility at the UT College of Pharmacy. This semester’s topics include the college's Dr. Carolyn Brown DEAI Champion Award recipients, a message from Pharmacy Council's DEAI chair, a university three-part series on midwives hosted by UT Pharmacy, our newest member of the DEAI team, and many more.
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.
These DEAI Champions have demonstrated exceptional efforts and continue to make significant contributions to creating a more diverse, equitable, accessible and inclusive culture within the college and beyond through their excellent service, teaching, research and/or academic endeavors.
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.
The college's Pharmaceutical Engineering and 3D Printing (PharmE3D) labs, led by Assistant Professor in Molecular Pharmaceutics and Drug Delivery Mohammed (Mo) Maniruzzaman, Ph.D., has recently earned several national and international awards and scholarships for outstanding research contributions to the field of pharmaceutical science and technology.
The college's new Building Our Own Talent (BOOT) program is designed to provide mentoring and support for trainees and embrace the notion that innovation and discovery thrive in an inclusive culture that values diverse ideas. This year’s recipients enter the pharmaceutical sciences graduate program: Charlene Mandimutsira joins the chemical biology and medicinal chemistry (CBMC) track and Kelsey Strey joins the pharmacotherapy (PT) track.
Division Head and Professor of Molecular Pharmaceutics and Drug Delivery Dr. Bill Williams was on KXAN News to talk about promising new data from TFF Pharmaceuticals and Augmenta Bioworks. The companies plan to develop Dr. Williams' thin film freezing technology to better deliver antibody treatment directly to the lungs of COVID patients.
The University of Texas at Austin community members won several Emerging Leaders Spotlight Awards during the recent chapter meeting of the Texas Association of Diversity Officers in Higher Education (TADOHE). The inaugural awards seek to highlight and acknowledge individuals in higher education who actively support TADOHE’s mission and diversity, equity, accessibility and inclusion (DEAI) as a whole.